Nandyala Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 28-05-2024
- Paid Up Capital ₹ 0.10 M
as on 28-05-2024
- Company Age 2 Year, 8 Months
About Nandyala Pharma
The Company is engaged in the Chemicals Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anusha Nandyala and Santhosh Sabbavarapu serve as directors at the Company.
- CIN/LLPIN
U24230TG2022PTC161765
- Company No.
161765
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2022
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
K.V.Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nandyala Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anusha Nandyala  | Director | 19-Apr-2022 | Current |
| Santhosh Sabbavarapu | Director | 19-Apr-2022 | Current |
Financial Performance of Nandyala Pharma.
Enhance accessibility to Nandyala Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Nandyala Pharma?
Unlock access to Nandyala Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Nandyala Impex Private LimitedActive 2 years 8 monthsAnusha Nandyala and Santhosh Sabbavarapu are mutual person
- Nandyala Agritech Private LimitedActive 2 years 8 months
Anusha Nandyala and Santhosh Sabbavarapu are mutual person
- Nandyala Infra Projects Private LimitedActive 2 years 8 months
Anusha Nandyala and Santhosh Sabbavarapu are mutual person
- Nandyala Investments Private LimitedActive 2 years 10 months
Anusha Nandyala and Santhosh Sabbavarapu are mutual person
- Nandyala Innovative Solutions Private LimitedActive 2 years 8 months
Anusha Nandyala and Santhosh Sabbavarapu are mutual person
- Nandyala Innovation Index Organisation Private LimitedActive 2 years 8 months
Anusha Nandyala and Santhosh Sabbavarapu are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nandyala Pharma?
Nandyala Pharma has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nandyala Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nandyala Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
